Quick Takeaways
- STEMPOINT CAPITAL LP filed SCHEDULE 13G/A for Vistagen Therapeutics, Inc Common Stock, par value $0.001 per share ("Shares") (VTGN).
- Disclosed ownership: 8.2%.
- Date of event: 31 Dec 2024.
STEMPOINT CAPITAL LP - 31 Dec 2024 SCHEDULE 13G/A Report for Vistagen Therapeutics, Inc Common Stock, par value $0.001 per share ("Shares") (VTGN)
- Filing Manager
- STEMPOINT CAPITAL LP
- Reporting Manager
- StemPoint Capital LP
- Symbol
- VTGN
- Shares outstanding
- 28,396,244 shares
- Disclosed Ownership
- 2,328,492 shares
- Ownership
- 8.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 13:01:57 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"STEMPOINT CAPITAL LP disclosed 8.2% ownership in Vistagen Therapeutics, Inc Common Stock, par value $0.001 per share ("Shares") (VTGN) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 13:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| StemPoint Capital LP | 8.2% | 2,328,492 | 0 | 2,053,842 | /s/ Sean C. Tan | Sean C. Tan, Authorized Signatory | |
| StemPoint Capital Management GP LLC | 8.2% | 2,328,492 | 0 | 2,053,842 | /s/ Sean C. Tan | Sean C. Tan, Authorized Signatory | |
| Michelle Ross | 8.2% | 2,328,492 | 0 | 2,053,842 | /s/ Michelle Ross | Michelle Ross |